Abstract OT1-01-07: nab-paclitaxel (nab-P) plus nivolumab (Nivo) in human epidermal growth factor receptor 2 (HER2)–negative recurrent metastatic breast cancer (MBC)
Year: 2016
Type: conference-abstract
Source: Cancer Research
Institutions: Hackensack University Medical Center, University of California, Los Angeles, Medical College of Wisconsin, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Moffitt Cancer Center, Oncology Hematology Care, Celgene (United States), The Ohio State University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2397600876